UPDATE 2-Viatris to buy pain therapy maker Pacira BioSciences for $1.65 billion

2

(Adds shares in paragraph 2, details in paragraph 5, 8, and 9, background in paragraph 6, 7, 10 and 11) Oct 8 (Reuters) – Drugmaker Viatris will buy Pacira BioSciences for $1.65 billion in an all-cash

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)